Michael Kiernan to Disease Progression
This is a "connection" page, showing publications Michael Kiernan has written about Disease Progression.
Connection Strength
0.060
-
Dunlay SM, Pinney SP, Lala A, Stewart GC, McIlvennan C, Wong RP, Morris AA, Pagani FD, Allen LA, Breathett K, Cogswell R, Colvin MM, Cowger JA, Drakos SG, Gelfman LP, Kanwar MK, Kiernan MS, Kittleson MM, Lewis EF, Moazami N, Ogunniyi MO, Pandey A, Rogers JG, Schumacher KR, Slaughter MS, Tedford RJ, Teuteberg J, Valantine HA, DeFilippis EM, Dixon DD, Golbus JR, Gulati G, Hanff TC, Hsiao S, Lewsey SC, McCormick AD, Nayak A, Fenton KN, Longacre LS, Shanbhag SM, Taddei-Peters WC, Stevenson LW. Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to Action. JAMA Cardiol. 2025 Apr 01; 10(4):391-398.
Score: 0.043
-
Kapur NK, Heffernan KS, Yunis AA, Parpos P, Kiernan MS, Sahasrabudhe NA, Kimmelstiel CD, Kass DA, Karas RH, Mendelsohn ME. Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failure. Am J Cardiol. 2010 Dec 15; 106(12):1770-6.
Score: 0.016